Literature DB >> 1316356

Substrates and signalling complexes: the tortured path to insulin action.

R A Roth1, B Zhang, J E Chin, K Kovacina.   

Abstract

In the last few years several potential substrates of the insulin receptor tyrosine kinase have been identified, purified, and their cDNAs isolated. These putative substrates include: 1) pp15, a fatty acid-binding protein; 2) pp120, a plasma membrane ecto-ATPase; 3) pp42, a MAP serine/threonine kinase; 4) pp85, a subunit of the Type 1 phosphatidylinositol kinase; and 5) pp185, a phosphatidylinositol kinase binding protein. Although the tyrosine phosphorylation of several of these substrates correlates with the signalling capabilities of various mutant receptors, the role of these substrates in mediating any one of insulin's many biological responses is still unknown. In addition, recent data indicate that the tyrosine phosphorylation of pp42 may in fact be due to autophosphorylation, thereby removing it from the list of putative substrates of the insulin receptor kinase. Finally, the present review discusses the question of whether signalling occurs as a result of the tyrosine phosphorylation of substrates or via the formation of signalling complexes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316356     DOI: 10.1002/jcb.240480104

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  The alpha subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway.

Authors:  D X Ding; C I Rivas; M L Heaney; M A Raines; J C Vera; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

2.  Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes.

Authors:  R Kooijman; J J Lauf; A C Kappers; G T Rijkers
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.